RecruitingNCT06056908

Shwachman Diamond Syndrome Registry and Study

Shwachman Diamond Syndrome Registry and Study (SDS Registry)


Sponsor

Boston Children's Hospital

Enrollment

5,000 participants

Start Date

Jan 19, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

Shwachman-Diamond syndrome (SDS) is a genetic condition characterized by bone marrow failure, medical co-morbidities, and leukemia predisposition. SDS-Like patients share clinical features with SDS but lack mutations in known SDS genes. Since SDS/SDS-Like syndromes are rare diseases, data are sparse regarding the clinical features, natural history, clinical outcomes with current management, and treatment. For this reason, the SDS Registry was formed to collect clinical data from medical records and to bank biological samples with the goal of understanding SDS/SDS-Like diseases to develop better treatments and improve the health of patients with these conditions.


Eligibility

Inclusion Criteria5

  • Biallelic mutations in SBDS, or pathogenic mutations in DNAJC21, EFL1, or SRP54 OR
  • Shwachman-Diamond Syndrome defined clinically OR
  • Clinically suspected Shwachman-Diamond Syndrome OR
  • Phenotypic features suggestive of SDS OR
  • Parents, siblings, and other blood relatives of any age, living and deceased, of patients with SDS or SDS-Like conditions are eligible for this study

Exclusion Criteria1

  • • Patients with other diagnosed causes of bone marrow failure, exocrine pancreatic insufficiency and cancer predisposition will be excluded.

Locations(4)

Children's Hospital Colorado

Aurora, Colorado, United States

Boston Children's Hospital

Boston, Massachusetts, United States

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06056908


Related Trials